We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report.
- Authors
Iwata, Yoshinori; Matsuhashi, Nobuhisa; Takahashi, Takao; Suetsugu, Tomonari; Fukada, Masahiro; Yasufuku, Itaru; Imai, Takeharu; Tanahashi, Toshiyuki; Matsui, Satoshi; Imai, Hisashi; Tanaka, Yoshihiro; Yamaguchi, Kazuya; Yoshida, Kazuhiro
- Abstract
Development of diabetic ketoacidosis (DKA) caused by fulminant type 1 diabetes (FT1D) during administration of uracil-tegafur (UFT) with leucovorin (LV) as adjuvant chemotherapy is extremely rare. Here, we report a case of DKA caused by FT1D during administration of UFT with LV as adjuvant chemotherapy for colon cancer. A woman in her 60s was transferred to the emergency medical center of our hospital with complaints of impaired consciousness and vomiting. She had undergone left hemicolectomy and D3 lymph node dissection for transverse colon cancer 8 months earlier. She was provided UFT with LV as adjuvant chemotherapy. Laboratory analysis revealed hyperglycemia, high anion gap metabolic acidosis and urinary ketones. She was diagnosed with DKA and was started on intravenous infusion of fluid and continuous subcutaneous insulin injections. Following admission, she was examined and diagnosed with FT1D. The present case describes an extremely rare case of DKA caused by FT1D during adjuvant chemotherapy with UFT + LV for colon cancer.
- Subjects
TYPE 1 diabetes; DIABETIC acidosis; ADJUVANT treatment of cancer; CANCER chemotherapy; COLON cancer
- Publication
Molecular & Clinical Oncology, 2019, Vol 11, Issue 2, p189
- ISSN
2049-9450
- Publication type
Article
- DOI
10.3892/mco.2019.1862